INTRODUCTION: An efficient fully automated method for the radiosynthesis of enantiomerically pure O-(2-[(18)F]fluoroethyl)-L-tyrosine ([(18)F]FET) using the GE TracerLab FX(FN) synthesis module via the O-(2-tosyloxyethyl)-N-trityl-L-tyrosine tert-butylester precursor has been developed. METHODS: The radiolabelling of [(18)F]FET involved a classical [(18)F]fluoride nucleophilic substitution performed in acetonitrile using potassium carbonate and Kryptofix 222, followed by acid hydrolysis using 2N hydrochloric acid. RESULTS: [(18)F]FET was produced in 35±5% (n=22) yield non-decay-corrected (55±5% decay-corrected) and with radiochemical and enantiomeric purity of >99% with a specific activity of >90 GBq/μmol after 63 min of radiosynthesis including HPLC purification and formulation. CONCLUSION: The automated radiosynthesis provides high and reproducible yields suitable for routine clinical use. Crown
INTRODUCTION: An efficient fully automated method for the radiosynthesis of enantiomerically pure O-(2-[(18)F]fluoroethyl)-L-tyrosine ([(18)F]FET) using the GE TracerLab FX(FN) synthesis module via the O-(2-tosyloxyethyl)-N-trityl-L-tyrosine tert-butylester precursor has been developed. METHODS: The radiolabelling of [(18)F]FET involved a classical [(18)F]fluoride nucleophilic substitution performed in acetonitrile using potassium carbonate and Kryptofix 222, followed by acid hydrolysis using 2N hydrochloric acid. RESULTS: [(18)F]FET was produced in 35±5% (n=22) yield non-decay-corrected (55±5% decay-corrected) and with radiochemical and enantiomeric purity of >99% with a specific activity of >90 GBq/μmol after 63 min of radiosynthesis including HPLC purification and formulation. CONCLUSION: The automated radiosynthesis provides high and reproducible yields suitable for routine clinical use. Crown
Authors: Shehzahdi S Moonshi; Romain Bejot; Zeenat Atcha; Vimalan Vijayaragavan; Kishore K Bhakoo; Julian L Goggi Journal: Am J Nucl Med Mol Imaging Date: 2013-09-19
Authors: Katharina Lückerath; Constantin Lapa; Annika Spahmann; Gerhard Jörg; Samuel Samnick; Andreas Rosenwald; Herrmann Einsele; Stefan Knop; Andreas K Buck Journal: PLoS One Date: 2013-12-23 Impact factor: 3.240
Authors: Constantin Lapa; Thomas Linsenmann; Katharina Lückerath; Samuel Samnick; Ken Herrmann; Carolin Stoffer; Ralf-Ingo Ernestus; Andreas K Buck; Mario Löhr; Camelia-Maria Monoranu Journal: PLoS One Date: 2015-03-25 Impact factor: 3.240
Authors: Jeroen Verhoeven; Fabian Hulpia; Ken Kersemans; Julie Bolcaen; Stef De Lombaerde; Jan Goeman; Benedicte Descamps; Giorgio Hallaert; Caroline Van den Broecke; Karel Deblaere; Christian Vanhove; Johan Van der Eycken; Serge Van Calenbergh; Ingeborg Goethals; Filip De Vos Journal: Sci Rep Date: 2019-02-27 Impact factor: 4.379
Authors: I-Hong Shih; Fan-Lin Kong; Mohammad S Ali; Yinhan Zhang; Dong-Fang Yu; Xudong Duan; David J Yang Journal: Biomed Res Int Date: 2013-07-09 Impact factor: 3.411
Authors: David Y Lewis; Richard Mair; Alan Wright; Kieren Allinson; Scott K Lyons; Tom Booth; Julia Jones; Robert Bielik; Dmitry Soloviev; Kevin M Brindle Journal: Theranostics Date: 2018-07-01 Impact factor: 11.556
Authors: Ksenia Lisova; Bao Ying Chen; Jia Wang; Kelly Mun-Ming Fong; Peter M Clark; R Michael van Dam Journal: EJNMMI Radiopharm Chem Date: 2019-12-31